Hypofractionated WPPT With HDR Boost

Clinical trial NCT06591819 · RECRUITING

Trial details

NCT number: NCT06591819
Sponsor: Abramson Cancer Center at Penn Medicine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2025-01-15
Primary completion: 2034-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.